ClinicalTrials.gg
RecruitingNCT07718321StimolIrpiniaUpdated Jul 21, 2026

Feasibility and Acceptability of StimolIrpinia for Cognitive Rehabilitation After Severe Acquired Brain Injury

An interventional study of StimolIrpinia-supported cognitive rehabilitation activities in Severe Acquired Brain Injury, Cognitive Impairment and Cognitive Rehabilitation, sponsored by Alfonso Magliacano. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Alfonso Magliacano · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This single-center pilot study evaluates the feasibility, acceptability, usability, and preliminary stimulus validation of StimolIrpinia, a multimedia repository of culturally and territorially relevant autobiographical stimuli designed to support cognitive rehabilitation activities in patients with severe acquired brain injury (sABI). The repository includes images, videos, maps, local cultural information, and printable materials related to the Irpinia area in Campania, Italy. Healthy adult volunteers will review the stimuli for their ability to evoke autobiographical memories, familiarity, emotional activation, and pleasantness. Hospitalized patients with sABI will complete six 30-minute StimolIrpinia-supported rehabilitation sessions over two weeks in addition to their routine comprehensive rehabilitation program. Rehabilitation professionals will receive standardized training and will use the repository to personalize cognitive rehabilitation exercises. Usability and acceptability will be evaluated from both patient and operator perspectives.

Read the detailed description

Patients with severe acquired brain injury often present impairments in attention, memory, language, executive functions, visuospatial abilities, perception, reasoning, and learning. Traditional cognitive rehabilitation commonly uses standardized paper-and-pencil exercises, but the generalization of gains from abstract tasks to everyday functioning can be limited. StimolIrpinia was developed to provide ecological, culturally familiar, and emotionally meaningful material that can be flexibly integrated by rehabilitation professionals into ordinary cognitive rehabilitation activities.

StimolIrpinia is not medical software and is not a medical device under Regulation (EU) 2017/745. It is a structured repository of multimedia rehabilitation-support materials. It does not provide clinical indications, treatment protocols, decision support, automated scoring, or autonomous therapeutic functions. The materials are selected and used under the responsibility of the rehabilitation professional within routine clinical practice.

The repository contains 118 multimedia maps representing towns in the Irpinia geographic area and six macro-areas: Partenio; Valle Ufita-Baronia; Serinese-Solofrana; Alta Irpinia; Vallo di Lauro-Baianese; and Terminio-Cervialto. Each map may include historical and contemporary photographs, links for virtual territorial exploration, information on local patron saints and traditional inhabitants' nicknames, and images or recipes of typical dishes. Printable cards and a practical guide support the operator in proposing personalized cognitive activities, including cognitive estimation, memory, spatial orientation, language, autobiographical memory, orientation, recognition, and gnosic exercises.

The study has two main components. First, a stimulus-validation phase will involve healthy adults who have lived for a prolonged period in the territory represented by the repository. Second, a usability phase will involve hospitalized sABI patients and rehabilitation professionals. Patients will complete six StimolIrpinia-supported sessions over two weeks, while continuing their routine rehabilitation program. At the end of the sessions, patients and operators will complete usability and acceptability measures and will provide qualitative feedback.

02

Conditions studied

  • Severe Acquired Brain Injury
  • Cognitive Impairment
  • Cognitive Rehabilitation
  • Neurorehabilitation

Keywords

  • severe acquired brain injury
  • cognitive rehabilitation
  • ecological rehabiliation
  • autobiographical stimuli
  • multimedia repository
  • acceptability
  • usability
  • feasibility
  • irpinia
03

In context

Brain Injuries

946 studies on the registry are indexed under Brain Injuries; 235 are open to participants now.

This study's planned enrollment of 10 is below the median of 41 across 612 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Alfonso Magliacano is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Patients With Severe Acquired Brain Injury - Inclusion Criteria

  • Age between 18 and 75 years.
  • Level of Cognitive Functioning (LCF) score >= 5 at study entry.
  • Stable clinical diagnosis, assessed by at least four repeated LCF evaluations within a 1-week time window.
  • History of severe acquired brain injury of traumatic, anoxic, vascular, or mixed etiology, defined as Glasgow Coma Scale score \<= 8 for at least 24 hours after brain injury.
  • Pathological performance on at least one Oxford Cognitive Screening (OCS) subscale.
  • Having lived for a prolonged period in the Irpinia area, including Partenio, Valle Ufita-Baronia, Serinese-Solofrana, Alta Irpinia, Vallo di Lauro-Baianese, and/or Terminio-Cervialto.
  • Written signed by the patient or by the patient's legal representative.

Patients With Severe Acquired Brain Injury - Exclusion Criteria • Severe medical conditions that may prevent participation in rehabilitation sessions, including severe language deficits incompatible with understanding instructions, severe cardiovascular instability, photosensitive or reflex epilepsy, and disabling visual or hearing deficits.

Rehabilitation Professionals/Operators - Inclusion Criteria

  • Age >= 18 years.
  • Proven experience in neuromotor and/or cognitive rehabilitation of patients with severe acquired brain injury.
  • Written informed consent to participate in the study.

Rehabilitation Professionals/Operators - Exclusion Criteria

  • Participation in the development of the StimolIrpinia repository, resulting in prior familiarity with the repository.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Patients receiving StimolIrpinia-supported cognitive rehabilitation

    Inpatients with severe acquired brain injury will receive six 30-minute sessions of cognitive rehabilitation activities supported by the StimolIrpinia multimedia repository, delivered three times per week for two weeks, in addition to routine comprehensive rehabilitation.

    Behavioral: StimolIrpinia-supported cognitive rehabilitation activities

Interventions

  • BehavioralStimolIrpinia-supported cognitive rehabilitation activities

    StimolIrpinia is a multimedia repository of autobiographical and territorially relevant stimuli from the Irpinia area, including images, videos, iconographic materials, cultural information, local landmarks, traditional foods, and links to virtual exploration tools. The repository is not a medical device and does not provide autonomous therapeutic, diagnostic, or decision-support functions. Patients will receive six 30-minute sessions over two weeks. During each session, the operator will select multimedia materials and exercises according to the patient's life experiences, familiarity with the Irpinia area, and cognitive profile. Activities may include memory exercises, language exercises, spatial orientation tasks, autobiographical memory stimulation, recognition tasks, and gnosic activities. All patients will continue their routine comprehensive rehabilitation program.

06

What researchers measure

Primary outcomes

  1. Patient-reported System Usability Scale score for StimolIrpinia

    Usability of StimolIrpinia from the patient perspective will be assessed using the System Usability Scale. The System Usability Scale total score ranges from 0 to 100, with higher scores indicating greater perceived usability.

    Time frame: Day 15, after completion of the 2-week intervention

  2. Healthcare professional-reported System Usability Scale score for StimolIrpinia

    Usability of StimolIrpinia from the healthcare professional perspective will be assessed using the System Usability Scale. The System Usability Scale total score ranges from 0 to 100, with higher scores indicating greater perceived usability.

    Time frame: After completion of each healthcare professional's assigned StimolIrpinia sessions, up to 12 months

Secondary outcomes

  1. Patient-reported Acceptability of Intervention Measure score for StimolIrpinia

    Acceptability of StimolIrpinia from the patient perspective will be assessed using the Acceptability of Intervention Measure. The measure includes 4 items rated on a 5-point Likert scale. The mean score ranges from 1 to 5, with higher scores indicating greater perceived acceptability.

    Time frame: Day 15, after completion of the 2-week intervention

  2. Patient-reported Intervention Appropriateness Measure score for StimolIrpinia

    Perceived appropriateness of StimolIrpinia from the patient perspective will be assessed using the Intervention Appropriateness Measure. The measure includes 4 items rated on a 5-point Likert scale. The mean score ranges from 1 to 5, with higher scores indicating greater perceived appropriateness.

    Time frame: Day 15, after completion of the 2-week intervention

  3. Patient-reported Feasibility of Intervention Measure score for StimolIrpinia

    Perceived feasibility of StimolIrpinia from the patient perspective will be assessed using the Feasibility of Intervention Measure. The measure includes 4 items rated on a 5-point Likert scale. The mean score ranges from 1 to 5, with higher scores indicating greater perceived feasibility.

    Time frame: Day 15, after completion of the 2-week intervention

  4. Healthcare professional-reported Acceptability of Intervention Measure score for StimolIrpinia

    Acceptability of StimolIrpinia from the healthcare professional perspective will be assessed using the Acceptability of Intervention Measure. The measure includes 4 items rated on a 5-point Likert scale. The mean score ranges from 1 to 5, with higher scores indicating greater perceived acceptability.

    Time frame: After completion of each healthcare professional's assigned StimolIrpinia sessions, up to 12 months

  5. Healthcare professional-reported Intervention Appropriateness Measure score for StimolIrpinia

    Perceived appropriateness of StimolIrpinia from the healthcare professional perspective will be assessed using the Intervention Appropriateness Measure. The measure includes 4 items rated on a 5-point Likert scale. The mean score ranges from 1 to 5, with higher scores indicating greater perceived appropriateness.

    Time frame: After completion of each healthcare professional's assigned StimolIrpinia sessions, up to 12 months

  6. Healthcare professional-reported Feasibility of Intervention Measure score for StimolIrpinia

    Perceived feasibility of StimolIrpinia from the healthcare professional perspective will be assessed using the Feasibility of Intervention Measure. The measure includes 4 items rated on a 5-point Likert scale. The mean score ranges from 1 to 5, with higher scores indicating greater perceived feasibility.

    Time frame: After completion of each healthcare professional's assigned StimolIrpinia sessions, up to 12 months

Other outcomes

  1. Number of completed StimolIrpinia sessions

    Adherence to the StimolIrpinia-supported rehabilitation sessions will be assessed as the number of completed sessions out of the 6 planned sessions. The score ranges from 0 to 6, with higher values indicating greater adherence.

    Time frame: From Day 1 to Day 15

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • - De Luca, R., Maggio, M. G., Naro, A., Portaro, S., Cannavò, A., & Calabrò, R. S. (2020). Can patients with severe traumatic brain injury be trained with cognitive telerehabilitation? An inpatient feasibility and usability study. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 79, 246-250. https://doi.org/10.1016/j.jocn.2020.07.063 - Faulkner L. Beyond the five-user assumption: Benefits of increased sample sizes in usability testing. Behav Res Methods Instrum Comput. 2003;35(3):379-383. doi:10.3758/BF03195514 - Hwang W, Salvendy G. Number of people required for usability evaluation: The 10 ± 2 rule. Commun ACM. 2010;53(5):130-133. doi:10.1145/1735223.1735255 - Kunselman AR. Pilot studies and feasibility studies in clinical research. J Biopharm Stat. 2024;34(1):1-12. - Magliacano, A., Fiorentino, M. R., Scarano, G., Colella, M., Fasano, C., Spinola, M., Monda, A., Estraneo, A., & VR-sABI study group (2025). Non-immersive virtual reality for cognitive rehabilitation of individuals with severe acquired brain injury (VR-sABI): study protocol for a multicentric randomized controlled trial. Trials, 26(1), 392. https://doi.org/10.1186/s13063-025-09128-7 - Ponsford J, Sloan S, Snow P. Traumatic brain injury: Rehabilitation for everyday adaptive living. 2nd ed. New York: Psychology Press; 2013. - Wilson BA. Memory rehabilitation: Integrating theory and practice. New York: Guilford Press; 2009. - Woods B, Spector AE, Jones CA, Orrell M, Davies SP. Reminiscence therapy for dementia. Cochrane Database Syst Rev. 2005;(2):CD001120. doi:10.1002/14651858.CD001120.pub2

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07718321
Lead sponsor
Alfonso Magliacano
Responsible party
Alfonso Magliacano (Researcher, Psychologist, PhD, Fondazione Don Carlo Gnocchi ETS) — Sponsor-investigator
First posted
Jul 21, 2026
Start date
Jun 22, 2026
Primary completion
Aug 22, 2027 (estimated)
Completion
Aug 22, 2027 (estimated)
Last update
Jul 21, 2026

Study contacts

Alfonso Magliacano
Contact
amagliacano@dongnocchi.it
393387389414

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion